These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31147684)

  • 1. Impact of delivery characteristics on dose delivery accuracy of volumetric modulated arc therapy for different treatment sites.
    Li J; Zhang X; Li J; Jiang R; Sui J; Chan MF; Yang R
    J Radiat Res; 2019 Oct; 60(5):603-611. PubMed ID: 31147684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.
    Agnew CE; Irvine DM; McGarry CK
    J Appl Clin Med Phys; 2014 Nov; 15(6):4994. PubMed ID: 25493524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
    Masi L; Doro R; Favuzza V; Cipressi S; Livi L
    Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of beam complexity in intensity-modulated radiation therapy treatment plans.
    Du W; Cho SH; Zhang X; Hoffman KE; Kudchadker RJ
    Med Phys; 2014 Feb; 41(2):021716. PubMed ID: 24506607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online adaptation and verification of VMAT.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a plan complexity mitigation algorithm based on gamma passing rate predictions for volumetric-modulated arc therapy.
    Ono T; Nakamura M; Ono Y; Nakamura K; Mizowaki T
    Med Phys; 2022 Mar; 49(3):1793-1802. PubMed ID: 35064567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
    Park SY; Kim IH; Ye SJ; Carlson J; Park JM
    Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of plan parameters and modulation indices on patient-specific QA results for standard and stereotactic VMAT.
    Chun M; Joon An H; Kwon O; Oh DH; Park JM; Kim JI
    Phys Med; 2019 Jun; 62():83-94. PubMed ID: 31153402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans.
    Park JM; Kim JI; Park SY; Oh DH; Kim ST
    Radiat Oncol; 2018 Sep; 13(1):175. PubMed ID: 30217163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive formulation for volumetric modulated arc therapy planning.
    Nguyen D; Lyu Q; Ruan D; O'Connor D; Low DA; Sheng K
    Med Phys; 2016 Jul; 43(7):4263. PubMed ID: 27370141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using machine learning to predict gamma passing rate in volumetric-modulated arc therapy treatment plans.
    Salari E; Shuai Xu K; Sperling NN; Parsai EI
    J Appl Clin Med Phys; 2023 Feb; 24(2):e13824. PubMed ID: 36495010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description and evaluation of a new volumetric-modulated arc therapy plan complexity metric.
    Li G; Jiang W; Li Y; Wang Q; Xiao J; Zhong R; Bai S
    Med Dosim; 2021 Summer; 46(2):188-194. PubMed ID: 33353791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commissioning and quality assurance for VMAT delivery systems: An efficient time-resolved system using real-time EPID imaging.
    Zwan BJ; Barnes MP; Hindmarsh J; Lim SB; Lovelock DM; Fuangrod T; O'Connor DJ; Keall PJ; Greer PB
    Med Phys; 2017 Aug; 44(8):3909-3922. PubMed ID: 28564208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the properties of IMRT and VMAT beams and evaluation against pre-treatment quality assurance results.
    Crowe SB; Kairn T; Middlebrook N; Sutherland B; Hill B; Kenny J; Langton CM; Trapp JV
    Phys Med Biol; 2015 Mar; 60(6):2587-601. PubMed ID: 25761616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer.
    Tamura M; Monzen H; Matsumoto K; Kubo K; Otsuka M; Inada M; Doi H; Ishikawa K; Nakamatsu K; Sumida I; Mizuno H; Yoon DK; Nishimura Y
    Radiat Oncol; 2018 Aug; 13(1):163. PubMed ID: 30170614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of Aperture Shape Controller on Knowledge-based VMAT Planning of Prostate Cancer].
    Ito T; Tamura M; Monzen H; Matsumoto K; Nakamatsu K; Harada T; Fukui T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2021; 77(1):23-31. PubMed ID: 33473076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT).
    Huang L; Zhuang T; Mastroianni A; Djemil T; Cui T; Xia P
    J Appl Clin Med Phys; 2016 May; 17(3):203-210. PubMed ID: 27167278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous aperture dose calculation and optimization for volumetric modulated arc therapy.
    Christiansen E; Heath E; Xu T
    Phys Med Biol; 2018 Oct; 63(21):21NT01. PubMed ID: 30362464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.